---
reference_id: "PMID:26497784"
title: "Retinal ganglion cell apoptotic pathway in glaucoma: Initiating and downstream mechanisms."
authors:
- Levkovitch-Verbin H
journal: Prog Brain Res
year: '2015'
doi: 10.1016/bs.pbr.2015.05.005
content_type: abstract_only
---

# Retinal ganglion cell apoptotic pathway in glaucoma: Initiating and downstream mechanisms.
**Authors:** Levkovitch-Verbin H
**Journal:** Prog Brain Res (2015)
**DOI:** [10.1016/bs.pbr.2015.05.005](https://doi.org/10.1016/bs.pbr.2015.05.005)

## Content

1. Prog Brain Res. 2015;220:37-57. doi: 10.1016/bs.pbr.2015.05.005. Epub 2015 Oct
 1.

Retinal ganglion cell apoptotic pathway in glaucoma: Initiating and downstream 
mechanisms.

Levkovitch-Verbin H(1).

Author information:
(1)Glaucoma Service, Goldschleger Eye Institute, Sheba Medical Center, 
Tel-Hashomer, Israel; Sackler Faculty of Medicine, Tel-Aviv University, 
Tel-Hashomer, Israel. Electronic address: halevko@hotmail.com.

Apoptosis of retinal ganglion cells (RGCs) in glaucoma causes progressive visual 
field loss, making it the primary cause of irreversible blindness worldwide. 
Elevated intraocular pressure and aging, the main risk factors for glaucoma, 
accelerate RGC apoptosis. Numerous pathways and mechanisms were found to be 
involved in RGC death in glaucoma. Neurotrophic factors deprivation is an early 
event. Oxidative stress, mitochondrial dysfunction, inflammation, glial cell 
dysfunction, and activation of apoptotic pathways and prosurvival pathways play 
a significant role in RGC death in glaucoma. The most important among the 
involved pathways are the MAP-kinase pathway, PI-3 kinase/Akt pathway, Bcl-2 
family, caspase family, and IAP family.

Â© 2015 Elsevier B.V. All rights reserved.

DOI: 10.1016/bs.pbr.2015.05.005
PMID: 26497784 [Indexed for MEDLINE]